[P1] Poster Session (1) / Corporate Exhibits

Flash TalksInfectious Disease Medicine

[P1-02] Development of a Novel Therapeutic Strategy for the Elimination of Hepatitis B Virus DNA Using CRISPR-Cas3

*Yoshiki Saiki¹, Kazuto Yoshimi¹, Masahiko Ito², Tetsuro Suzuki², Yumi Kanegae¹, Tomoji Mashimo¹ (1. Division of Animal Genetics, Laboratory Animal Research Center, Institute of Medical Science , The University of Tokyo (Japan), 2. Department of Microbiology and Immunology, Hamamatsu University School of Me dicine (Japan))

Keywords:

Gene editing,CRISPR-Cas,Hepatitis B virus

Password required to view

Log in

or